Selina M. Luger

Selina M. Luger, MD is a Professor of Medicine specializing in Hematology-Oncology at the University of Pennsylvania, with clinical practice at the Abramson Cancer Center and Perelman Center for Advanced Medicine in Philadelphia. She maintains active hospital privileges at the Hospital of the University of Pennsylvania and sees patients aged 18+ for complex blood disorders and malignancies.

Her educational background includes:

• Medical School: McGill University
• Residency: Presbyterian University Hospital
• Fellowship: Hospital of the University of Pennsylvania

Dr. Luger's research spans acute leukemias, hematopoietic cell transplantation, and health equity, with recent work on clonal hematopoiesis dynamics, immunotherapy integration, and social determinants affecting cancer outcomes. Her innovative DETECT trial applies biomarker science to stroke diagnostics.

Analysis of her 2025 publications reveals three dominant trends: 1) Disparities research examining racial/socioeconomic barriers in AML treatment; 2) Translational leukemia studies on genetic drivers of relapse; and 3) Clinical trial leadership in academic-community partnerships for rare leukemias.

Patient satisfaction metrics demonstrate exceptional clinical impact:

• 4.9/5.0 average rating from 452 reviews
• Consistent praise for communication clarity and compassionate care
• Recognition for expertise in complex leukemia management

As a mentor, Dr. Luger guides hematology-oncology fellows through Penn's training programs while leading multi-center trials like ECOG-ACRIN EA9131. Her research program integrates clinical care with NIH-funded studies on novel therapeutic approaches and health services optimization. Though no dedicated lab is specified, her work operates through the Abramson Cancer Center's collaborative infrastructure with extensive national/international partnerships in leukemia research.